Candida spp. in Lower Respiratory Tract Secretions – A Ten Years Retrospective Study

1Leroy O, Gangneux J-P, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006). Critical Care Medicine 2009; 37: 1612–1618.Leroy O Gangneux J-P Montravers P et al Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006) Critical Care Medicine 2009 37 1612 161810.1097/CCM.0b013e31819efac019325476Search in Google Scholar

2Wong LK, Barry AL, Horgan SM. Comparison of six different criteria for judging the acceptability of sputum specimens. Journal of Clinical Microbiology 1982; 16: 627–631.Wong LK Barry AL Horgan SM Comparison of six different criteria for judging the acceptability of sputum specimens Journal of Clinical Microbiology 1982 16 627 63110.1128/jcm.16.4.627-631.19822724347153311Search in Google Scholar

3Belibasakis GN. Microbiological changes of the ageing oral cavity. Archives of Oral Biology 2018; 96: 230–232.Belibasakis GN Microbiological changes of the ageing oral cavity Archives of Oral Biology 2018 96 230 23210.1016/j.archoralbio.2018.10.00130308473Search in Google Scholar

4Fanello S, Bouchara JP, Sauteron M, et al. Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients. Journal of Medical Microbiology, 2006; 55: 223–228.Fanello S Bouchara JP Sauteron M et al Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients Journal of Medical Microbiology 2006 55 223 22810.1099/jmm.0.46155-016434716Search in Google Scholar

5Ayhan M, Biṙengel MS, Yilmaz G, et al. Evaluaiton of Risk Factors for Candida Colonization and Infection in Non-Neutropenic Intensive Care Patients. Turkiye Klinikleri J Med Sci 2019; 39: 251–257.Ayhan M Biṙengel MS Yilmaz G et al Evaluaiton of Risk Factors for Candida Colonization and Infection in Non-Neutropenic Intensive Care Patients Turkiye Klinikleri J Med Sci 2019 39 251 25710.5336/medsci.2018-64511Search in Google Scholar

6Olaechea PM, Palomar M, León-Gil C, et al. Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient. Eur J Clin Microbiol Infect Dis 2004; 23: 323–330.Olaechea PM Palomar M León-Gil C et al Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient Eur J Clin Microbiol Infect Dis 2004 23 323 33010.1007/s10096-004-1104-x15024623Search in Google Scholar

7Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study. Clin Infect Dis 2004; 39: 309–317.Wisplinghoff H Bischoff T Tallent SM et al Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study Clin Infect Dis 2004 39 309 31710.1086/42194615306996Search in Google Scholar

8Barchiesi F, Orsetti E, Mazzanti S, et al. Candidemia in the elderly: What does it change? PLOS ONE 2017; 12: e0176576.Barchiesi F Orsetti E Mazzanti S et al Candidemia in the elderly: What does it change? PLOS ONE 2017 12 e017657610.1371/journal.pone.0176576542661228493896Search in Google Scholar

9Antinori S, Milazzo L, Sollima S, et al. Candidemia and invasive candidiasis in adults: A narrative review. European Journal of Internal Medicine 2016; 34: 21–28.Antinori S Milazzo L Sollima S et al Candidemia and invasive candidiasis in adults: A narrative review European Journal of Internal Medicine 2016 34 21 2810.1016/j.ejim.2016.06.02927394927Search in Google Scholar

10Sadeghi G, Ebrahimi-Rad M, Mousavi SF, et al. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile. Journal de Mycologie Médicale 2018; 28: 51–58.Sadeghi G Ebrahimi-Rad M Mousavi SF et al Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile Journal de Mycologie Médicale 2018 28 51 5810.1016/j.mycmed.2017.12.00829366545Search in Google Scholar

11Lamoth F, Lockhart SR, Berkow EL, et al. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother 2018; 73: i4–i13.Lamoth F Lockhart SR Berkow EL et al Changes in the epidemiological landscape of invasive candidiasis J Antimicrob Chemother 2018 73 i4 i1310.1093/jac/dkx44429304207Search in Google Scholar

12Isolated Candida infection of the lung. Respiratory Medicine Case Reports 2015; 16: 18–19.Isolated Candida infection of the lung Respiratory Medicine Case Reports 2015 16 18 1910.1016/j.rmcr.2015.03.001468189326744644Search in Google Scholar

13Meersseman W, Lagrou K, Spriet I, et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009; 35: 1526–1531.Meersseman W Lagrou K Spriet I et al Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study Intensive Care Med 2009 35 1526 153110.1007/s00134-009-1482-819357832Search in Google Scholar

14Sousa AS, Ferrito C, Paiva JA. Intubation-associated pneumonia: An integrative review. Intensive and Critical Care Nursing 2018; 44: 45–52.Sousa AS Ferrito C Paiva JA Intubation-associated pneumonia: An integrative review Intensive and Critical Care Nursing 2018 44 45 5210.1016/j.iccn.2017.08.00328869146Search in Google Scholar

15Barenfanger J, Arakere P, Cruz RD, et al. Improved Outcomes Associated with Limiting Identification of Candida spp. in Respiratory Secretions. Journal of Clinical Microbiology 2003; 41: 5645–5649.Barenfanger J Arakere P Cruz RD et al Improved Outcomes Associated with Limiting Identification of Candida spp in Respiratory Secretions. Journal of Clinical Microbiology 2003 41 5645 564910.1128/JCM.41.12.5645-5649.200330895614662955Search in Google Scholar

16Pendleton KM, Huffnagle GB, Dickson RP. The significance of Candida in the human respiratory tract: our evolving understanding. Pathog Dis; 75. Epub ahead of print 1 April 2017. DOI: 10.1093/femspd/ftx029.Pendleton KM Huffnagle GB Dickson RP The significance of Candida in the human respiratory tract: our evolving understanding Pathog Dis; 75. Epub ahead of print 1 April 2017 10.1093/femspd/ftx029643330028423168Open DOISearch in Google Scholar

17Castanheira M. Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations. J Clin Microbiol 2018; 56: e01907-17.Castanheira M Fungemia Surveillance in Denmark Demonstrates Emergence of Non-albicans Candida Species and Higher Antifungal Usage and Resistance Rates than in Other Nations J Clin Microbiol 2018 56 e01907 1710.1128/JCM.01907-17586981829436419Search in Google Scholar

18Williamson DR, Albert M, Perreault MM, et al. The relationship between Candida species cultured from the respiratory tract and systemic inflammation in critically ill patients with ventilator-associated pneumonia. Can J Anaesth 2011; 58: 275–284.Williamson DR Albert M Perreault MM et al The relationship between Candida species cultured from the respiratory tract and systemic inflammation in critically ill patients with ventilator-associated pneumonia Can J Anaesth 2011 58 275 28410.1007/s12630-010-9439-521287306Search in Google Scholar

19Hilty M, Burke C, Pedro H, et al. Disordered Microbial Communities in Asthmatic Airways. PLOS ONE 2010; 5: e8578.Hilty M Burke C Pedro H et al Disordered Microbial Communities in Asthmatic Airways PLOS ONE 2010 5 e857810.1371/journal.pone.0008578279895220052417Search in Google Scholar

20Zhang D, Wang Y, Shen S, et al. The mycobiota of the human body: a spark can start a prairie fire. Gut Microbes 2020; 11: 655–679.Zhang D Wang Y Shen S et al The mycobiota of the human body: a spark can start a prairie fire Gut Microbes 2020 11 655 67910.1080/19490976.2020.1731287752431532150513Search in Google Scholar

21Young S-H, Ostroff GR, Zeidler-Erdely PC, et al. A Comparison of the Pulmonary Inflammatory Potential of Different Components of Yeast Cell Wall. Journal of Toxicology and Environmental Health, Part A 2007; 70: 1116–1124.Young S-H Ostroff GR Zeidler-Erdely PC et al A Comparison of the Pulmonary Inflammatory Potential of Different Components of Yeast Cell Wall Journal of Toxicology and Environmental Health, Part A 2007 70 1116 112410.1080/1528739070121222417558806Search in Google Scholar

22Terraneo S, Ferrer M, Martín-Loeches I, et al. Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia. Clinical Microbiology and Infection 2016; 22: 94.e1-94.e8.Terraneo S Ferrer M Martín-Loeches I et al Impact of Candida spp isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia. Clinical Microbiology and Infection 2016 22 94e1-94.e810.1016/j.cmi.2015.09.00226369603Search in Google Scholar

23Sanguinetti M, Posteraro B, Lass-Flörl C. Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses 2015; 58 Suppl 2: 2–13.Sanguinetti M Posteraro B Lass-Flörl C Antifungal drug resistance among Candida species: mechanisms and clinical impact Mycoses 2015 58 Suppl 2 2 1310.1111/myc.1233026033251Search in Google Scholar

24Gunasekaran J, Saksena R, Jain M, et al. Can sputum gram stain be used to predict lower respiratory tract infection and guide empiric antimicrobial treatment: Experience from a tertiary care hospital. Journal of Microbiological Methods 2019; 166: 105731.Gunasekaran J Saksena R Jain M et al Can sputum gram stain be used to predict lower respiratory tract infection and guide empiric antimicrobial treatment: Experience from a tertiary care hospital Journal of Microbiological Methods 2019 166 10573110.1016/j.mimet.2019.10573131629914Search in Google Scholar

25Fukuyama H, Yamashiro S, Kinjo K, et al. Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study. BMC Infect Dis 2014; 14: 534.Fukuyama H Yamashiro S Kinjo K et al Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study BMC Infect Dis 2014 14 53410.1186/1471-2334-14-534428747525326650Search in Google Scholar

26Azoulay E, Cohen Y, Zahar J-R, et al. Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 2004; 30: 1384–1389.Azoulay E Cohen Y Zahar J-R et al Practices in non-neutropenic ICU patients with Candida-positive airway specimens Intensive Care Med 2004 30 1384 138910.1007/s00134-004-2316-315148568Search in Google Scholar

27Eggimann P, Pittet D. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med 2014; 40: 1429–1448.Eggimann P Pittet D Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later Intensive Care Med 2014 40 1429 144810.1007/s00134-014-3355-z417682824934813Search in Google Scholar

28Nguyen LDN, Viscogliosi E, Delhaes L. The lung mycobiome: an emerging field of the human respiratory microbiome. Front Microbiol 2015; 6: 89.Nguyen LDN Viscogliosi E Delhaes L The lung mycobiome: an emerging field of the human respiratory microbiome Front Microbiol 2015 6 8910.3389/fmicb.2015.00089432773425762987Search in Google Scholar

29Hamet M, Pavon A, Dalle F, et al. Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 2012; 38: 1272–1279.Hamet M Pavon A Dalle F et al Candida spp airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 2012 38 1272 127910.1007/s00134-012-2584-222699790Search in Google Scholar

30Roux D, Gaudry S, Dreyfuss D, et al. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat*. Critical Care Medicine 2009; 37: 1062–1067.Roux D Gaudry S Dreyfuss D et al Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat* Critical Care Medicine 2009 37 1062 106710.1097/CCM.0b013e31819629d219237918Search in Google Scholar

31Trejo-Hernández A, Andrade-Domínguez A, Hernández M, et al. Interspecies competition triggers virulence and mutability in Candida albicans – Pseudomonas aeruginosa mixed biofilms. The ISME Journal 2014; 8: 1974–1988.Trejo-Hernández A Andrade-Domínguez A Hernández M et al Interspecies competition triggers virulence and mutability in Candida albicans – Pseudomonas aeruginosa mixed biofilms The ISME Journal 2014 8 1974 198810.1038/ismej.2014.53418401824739628Search in Google Scholar

32Bandara HMHN, Panduwawala CP, Samaranayake LP. Biodiversity of the human oral mycobiome in health and disease. Oral Diseases 2019; 25: 363–371.Bandara HMHN Panduwawala CP Samaranayake LP Biodiversity of the human oral mycobiome in health and disease Oral Diseases 2019 25 363 37110.1111/odi.1289929786923Search in Google Scholar

33Fourie R, Pohl CH. Beyond Antagonism: The Interaction Between Candida Species and Pseudomonas aeruginosa. Journal of Fungi 2019; 5: 34.Fourie R Pohl CH Beyond Antagonism: The Interaction Between Candida Species and Pseudomonas aeruginosa Journal of Fungi 2019 5 3410.3390/jof5020034661736531010211Search in Google Scholar

34Nseir S, Jozefowicz E, Cavestri B, et al. Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study. Intensive Care Med 2007; 33: 137–142.Nseir S Jozefowicz E Cavestri B et al Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study Intensive Care Med 2007 33 137 14210.1007/s00134-006-0422-0709537217115135Search in Google Scholar

35Pfaller M, Neofytos D, Diekema D, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004– 2008. Diagnostic Microbiology and Infectious Disease 2012; 74: 323–331.Pfaller M Neofytos D Diekema D et al Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004– 2008. Diagnostic Microbiology and Infectious Disease 2012 74 323 33110.1016/j.diagmicrobio.2012.10.00323102556Search in Google Scholar

36Clancy CJ, Nguyen MH. Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care. Clin Infect Dis 2013; 56: 1284–1292.Clancy CJ Nguyen MH Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care Clin Infect Dis 2013 56 1284 129210.1093/cid/cit00623315320Search in Google Scholar

37Fortún J, Martín-Dávila P, Gómez-García de la Pedrosa E, et al. Emerging trends in candidemia: A higher incidence but a similar outcome. Journal of Infection 2012; 65: 64–70.Fortún J Martín-Dávila P Gómez-García de la Pedrosa E et al Emerging trends in candidemia: A higher incidence but a similar outcome Journal of Infection 2012 65 64 7010.1016/j.jinf.2012.02.01122369861Search in Google Scholar

38Adriana Monea, Luigi Santacroce, Massimo Marrelli, et al. Oral candidiasis and inflammatory response&58; A potential synergic contribution to the onset of Type-2 Diabetes Mellitus. Australasian Medical Journal 2017; 10: 550–556.Adriana Monea Luigi Santacroce Massimo Marrelli et al Oral candidiasis and inflammatory response&58; A potential synergic contribution to the onset of Type-2 Diabetes Mellitus Australasian Medical Journal 2017 10 550 556Search in Google Scholar

39Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. Infections in Patients with Diabetes Mellitus. Journal of Clinical Medicine 2019; 8: 76.Rodrigues CF Rodrigues ME Henriques M Candida sp Infections in Patients with Diabetes Mellitus. Journal of Clinical Medicine 2019 8 7610.3390/jcm8010076635219430634716Search in Google Scholar

40Petrovic SM, Radunovic M, Barac M, et al. Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects. PLOS ONE 2019; 14: e0210527.Petrovic SM Radunovic M Barac M et al Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects PLOS ONE 2019 14 e021052710.1371/journal.pone.0210527632819130629672Search in Google Scholar

41Ferreira EG, Yatsuda F, Pini M, et al. Implications of the presence of yeasts in tracheobronchial secretions of critically ill intubated patients. EXCLI J 2019; 18: 801–811.Ferreira EG Yatsuda F Pini M et al Implications of the presence of yeasts in tracheobronchial secretions of critically ill intubated patients EXCLI J 2019 18 801 811Search in Google Scholar

42Ergin F, Eren Tülek N, Yetkin MA, et al. Evaluation of Candida colonization in intensive care unit patients and the use of Candida colonization index. Mikrobiyol Bul 2013; 47: 305–317.Ergin F Eren Tülek N Yetkin MA et al Evaluation of Candida colonization in intensive care unit patients and the use of Candida colonization index Mikrobiyol Bul 2013 47 305 31710.5578/mb.476423621730Search in Google Scholar

43Ciurea CN, Kosovski I-B, Mare AD, et al. Candida and Candidiasis—Opportunism Versus Pathogenicity: A Review of the Virulence Traits. Microorganisms 2020; 8: 857.Ciurea CN Kosovski I-B Mare AD et al Candida and Candidiasis—Opportunism Versus Pathogenicity: A Review of the Virulence Traits Microorganisms 2020 8 85710.3390/microorganisms8060857735554032517179Search in Google Scholar

44Perkins SD, Woeltje KF, Angenent LT. Endotracheal tube biofilm inoculation of oral flora and subsequent colonization of opportunistic pathogens. International Journal of Medical Microbiology 2010; 300: 503–511.Perkins SD Woeltje KF Angenent LT Endotracheal tube biofilm inoculation of oral flora and subsequent colonization of opportunistic pathogens International Journal of Medical Microbiology 2010 300 503 51110.1016/j.ijmm.2010.02.00520510651Search in Google Scholar

45Cavalheiro M, Teixeira MC. Candida Biofilms: Threats, Challenges, and Promising Strategies. Front Med 2018; 5: 28.Cavalheiro M Teixeira MC Candida Biofilms: Threats, Challenges, and Promising Strategies Front Med 2018 5 2810.3389/fmed.2018.00028581678529487851Search in Google Scholar

46Andes D, Nett J, Oschel P, et al. Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model. Infection and Immunity 2004; 72: 6023–6031.Andes D Nett J Oschel P et al Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model Infection and Immunity 2004 72 6023 603110.1128/IAI.72.10.6023-6031.200451758115385506Search in Google Scholar

47Eix EF, Nett JE. How Biofilm Growth Affects Candida-Host Interactions. Front Microbiol 2020; 11: 1437.Eix EF Nett JE How Biofilm Growth Affects Candida-Host Interactions Front Microbiol 2020 11 143710.3389/fmicb.2020.01437732998032670252Search in Google Scholar

48Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm development. Nature Reviews Microbiology 2011; 9: 109–118.Finkel JS Mitchell AP Genetic control of Candida albicans biofilm development Nature Reviews Microbiology 2011 9 109 11810.1038/nrmicro2475389158721189476Search in Google Scholar

49Johnson CJ, Cabezas-Olcoz J, Kernien JF, et al. The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps. PLOS Pathogens 2016; 12: e1005884.Johnson CJ Cabezas-Olcoz J Kernien JF et al The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps PLOS Pathogens 2016 12 e100588410.1371/journal.ppat.1005884502134927622514Search in Google Scholar

50Uppuluri P, Chaturvedi AK, Srinivasan A, et al. Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle. PLoS Pathog 2010; 6: e1000828.Uppuluri P Chaturvedi AK Srinivasan A et al Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle PLoS Pathog 2010 6 e100082810.1371/journal.ppat.1000828284791420360962Search in Google Scholar

51Wall G, Montelongo-Jauregui D, Bonifacio BV, et al. Candida albicans biofilm growth and dispersal: contributions to pathogenesis. Current Opinion in Microbiology 2019; 52: 1–6.Wall G Montelongo-Jauregui D Bonifacio BV et al Candida albicans biofilm growth and dispersal: contributions to pathogenesis Current Opinion in Microbiology 2019 52 1 610.1016/j.mib.2019.04.001684267331085405Search in Google Scholar